Abstract Details
|
Ruth-Ann Marrie, MD, PhD
(University of Manitoba)
PRESENTER |
The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC. |
| No disclosure on file | |
| No disclosure on file | |
| James Marriott, MD, MSc (University of Toronto / BARLO MS Centre) | Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Marriott has received research support from Sanofi. The institution of Dr. Marriott has received research support from Roche. The institution of Dr. Marriott has received research support from Novartis. |
| No disclosure on file | |
| Michael B. Cossoy, MD (Health Sciences Centre) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file |